ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 018

Using the Electronic Health Record to Identify Subjects with Rheumatic Disease

Alysha Taxter1, Matthew Basiaga2, Rajdeep Pooni3, Caitlan Pinotti4, Lisa Buckley5 and CARRA Registry Investigators6, 1Nationwide Children's Hospital, Columbus, OH, 2Mayo Clinic, Rochester, MN, 3Stanford University, Palo Alto, CA, 4Duke, Durham, NC, 5Vanderbilt University Medical Center, Nashville, TN, 6CARRA, Washington, DC

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: dermatomyositis, Diagnostic criteria, informatics, Juvenile Inflammatory Arthritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, March 30, 2023

Title: Poster Breakout 2 - JIA & Uveitis: Genetics, Clinical & Therapeutic Aspects

Session Type: Breakout Session

Session Time: 5:10PM-5:40PM

Background/Purpose: Research teams spend hours manually searching the electronic health records (EHRs) to identify potential candidates eligible for recruitment to the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. There are multiple existing tools, including self-service reporting tools and more detailed data extraction methods, which may increase the efficiency of eligible subject identification. This study aims to build a predictive electronic algorithm to identify children with rheumatic disease using electronic health record data.

Methods: Five diverse clinical sites (Duke, Mayo, Nationwide Childrens, Stanford, Vanderbilt) evaluated currently available EHR reporting functionality and developed self-service queries. All sites used the same electronic health record vendor (Epic Systems Corporation). Available shared reporting tools were identified. Queries were created and evaluated for their sensitivity and positive predictive value of identifying children with juvenile arthritis (ICD10-CM M08.*, M35.7), lupus and associated conditions (M32.*, L93.*, H01.12, M35.*), and dermatomyositis (M33.*). The observation period was a convenience sample limited to two weeks duration; clinic schedules were reviewed to validate patients with these diagnosis, and were compared to the output of the queries. Descriptive statistics were used.

Results: Three automated extraction tools were identified. Clarity reports, which can pull nearly all EHR data with associated complex data linkages from Epics back-end database, requires custom programming and were not available without significant funding at most centers. Two other tools, Slicer-Dicer and Reporting Workbench, were available without cost, on-demand, and were readily available to be run by end-users. Slicer-Dicer was the easiest to configure and was further evaluated (Tables). The highest performing queries to identify patients with rheumatic disease included limiting queries by diagnosis, department, and encounter type. Although additional discrete data elements can be configured to report in Slicer-Dicer, these require access to specialized programming environments.

Conclusion: Although highly detailed reports can include additional variables and output, end-user usability was a key factor to configure and utilize on-demand and readily available reporting tools. Queries with high sensitivity and positive predictive value across all conditions included diagnosis, department, and encounter criteria. Enabling availability of additional discrete data elements could likely improve identification of children with rheumatic disease. Integration of reporting tools into research screening and recruitment workflows are needed.

Supporting image 1Sensitivity and Positive Predictive Value of Identifying Juvenile Idiopathic Arthritis Through Electronic Health Record Reporting Tools

Supporting image 2Sensitivity and Positive Predictive Value of Identifying Lupus and Associated Conditions Through Electronic Health Record Reporting Tools

Supporting image 3Sensitivity and Positive Predictive Value of Identifying Juvenile Dermatomyositis Through Electronic Health Record Reporting Tools


Disclosures: A. Taxter: None; M. Basiaga: None; R. Pooni: None; C. Pinotti: None; L. Buckley: None; C. Investigators: None.

To cite this abstract in AMA style:

Taxter A, Basiaga M, Pooni R, Pinotti C, Buckley L, Investigators C. Using the Electronic Health Record to Identify Subjects with Rheumatic Disease [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/using-the-electronic-health-record-to-identify-subjects-with-rheumatic-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-the-electronic-health-record-to-identify-subjects-with-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology